ALK is a research-driven global pharmaceutical company focusing on allergy diagnosis and treatment. ALK is a world leader in allergy immunotherapy — a treatment of the underlying cause of allergy. The company has approximately 2,000 employees with subsidiaries, production facilities and distributors worldwide.
The company is headquartered in Hørsholm, Denmark, and listed on NASDAQ Copenhagen.
ALK-Abelló Ltd is a member of the ABPI and abides by the Code of Practice for the Pharmaceutical Industry.